Simulation-Based Learning for Methadone and Buprenorphine Prescribing Skills

Intended Audience:

Nurse practitioners and physicians who completed the course Opioid use disorder treatment are looking to practice OAT prescribing skills in a safe, supportive environment.

Date and Time:

See dates below

Course Duration:

One-day virtual workshop

Location:

Cost:

$675

Contact Phone Number:

Please email

Contact Email:

courses.help@camh.ca

Course Requirements and Prerequisites

Completion of the Opioid Use Disorder Treatment Course is required. 

The course is offered as an opportunity for physicians and nurse practitioners to practice methadone prescribing skills in an environment that imitates real-life situations, without any risk to real patients.

Course Overview

The course provides opportunities to a practice prescribing skills of OAT medications.  Four learners are grouped with one facilitator, who is an experienced prescriber, and each simulation session is followed by a debried

Learning Objectives

• Conduct a comprehensive assessment of a patient for the suitability of OAT, including diagnosis for moderate-severe opioid use disorder.
  • Initiate patient's treatment with methadone  or buprenorphine-naloxone per clinical guideline
  • Titrate methadone and buprenorphine-naloxone to a stable dose based on assessment of patient
  • Manage OAT based on patient clinical stability during maintenance phase including: take-home doses, missed doses, and relapse events, in a manner that is safe for patient and the community

Delivery Method

The simulation learning comprises cases of patients; each includes simulated appointments in different points of time in their treatment. Each learner will have the opportunity to actively participate in three sessions of simulation and observe six other sessions, followed by debrief. The debriefs of the sessions will be led by facilitators and include trainees, peers and simulators.

Agenda

Certification and Accreditation

• This activity is an Accredited Simulation Activity (Section 3) as defined by the Maintenance of Certification Program of The Royal College of Physicians & Surgeons of Canada, and approved by the University of Toronto.
•  This Group Learning program has been certified by the College of Family Physicians of Canada for up to 13.50 Mainpro+ credits. (program ID: 192207)

Affiliation and Partnerships

University of Toronto

Register

Course start and end dates

October 17, 2021

Please select the link below to register:

https://app.certain.com/profile/3263232

Relevant Links and Resources

Centre for Addiction and Mental Health.

Opioid Agonist Therapy: A Synthesis of Canadian Guidelines for Treating Opioid Use Disorder.